159 related articles for article (PubMed ID: 28008934)
61. DNA Repair Gene Expression Adjusted by the
Peterson LE; Kovyrshina T
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30965671
[TBL] [Abstract][Full Text] [Related]
62. Mutation pattern analysis reveals polygenic mini-drivers associated with relapse after surgery in lung adenocarcinoma.
Bennett L; Howell M; Memon D; Smowton C; Zhou C; Miller CJ
Sci Rep; 2018 Oct; 8(1):14830. PubMed ID: 30287876
[TBL] [Abstract][Full Text] [Related]
63. Cancer-mutation network and the number and specificity of driver mutations.
Iranzo J; Martincorena I; Koonin EV
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6010-E6019. PubMed ID: 29895694
[TBL] [Abstract][Full Text] [Related]
64. Why Are Some Driver Mutations Rare?
Nussinov R; Tsai CJ; Jang H
Trends Pharmacol Sci; 2019 Dec; 40(12):919-929. PubMed ID: 31699406
[TBL] [Abstract][Full Text] [Related]
65. Chromatin regulators with tumor suppressor properties and their alterations in human cancers.
Shu XS; Li L; Tao Q
Epigenomics; 2012 Oct; 4(5):537-49. PubMed ID: 23130835
[TBL] [Abstract][Full Text] [Related]
66. Driver gene classification reveals a substantial overrepresentation of tumor suppressors among very large chromatin-regulating proteins.
Waks Z; Weissbrod O; Carmeli B; Norel R; Utro F; Goldschmidt Y
Sci Rep; 2016 Dec; 6():38988. PubMed ID: 28008934
[TBL] [Abstract][Full Text] [Related]
67. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
68. An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer.
Yang Z; Jones A; Widschwendter M; Teschendorff AE
Genome Biol; 2015 Jul; 16(1):140. PubMed ID: 26169266
[TBL] [Abstract][Full Text] [Related]
69. Interpreting pathways to discover cancer driver genes with Moonlight.
Colaprico A; Olsen C; Bailey MH; Odom GJ; Terkelsen T; Silva TC; Olsen AV; Cantini L; Zinovyev A; Barillot E; Noushmehr H; Bertoli G; Castiglioni I; Cava C; Bontempi G; Chen XS; Papaleo E
Nat Commun; 2020 Jan; 11(1):69. PubMed ID: 31900418
[TBL] [Abstract][Full Text] [Related]
70. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
[TBL] [Abstract][Full Text] [Related]
71. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
[TBL] [Abstract][Full Text] [Related]
72. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway.
Sheikh BN; Phipson B; El-Saafin F; Vanyai HK; Downer NL; Bird MJ; Kueh AJ; May RE; Smyth GK; Voss AK; Thomas T
Oncogene; 2015 Nov; 34(47):5807-20. PubMed ID: 25772242
[TBL] [Abstract][Full Text] [Related]
73. High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients.
Sung WW; Lin YM; Wu PR; Yen HH; Lai HW; Su TC; Huang RH; Wen CK; Chen CY; Chen CJ; Yeh KT
BMC Cancer; 2014 Dec; 14():951. PubMed ID: 25511643
[TBL] [Abstract][Full Text] [Related]
74. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Leiserson MD; Vandin F; Wu HT; Dobson JR; Eldridge JV; Thomas JL; Papoutsaki A; Kim Y; Niu B; McLellan M; Lawrence MS; Gonzalez-Perez A; Tamborero D; Cheng Y; Ryslik GA; Lopez-Bigas N; Getz G; Ding L; Raphael BJ
Nat Genet; 2015 Feb; 47(2):106-14. PubMed ID: 25501392
[TBL] [Abstract][Full Text] [Related]
75. Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening.
Zhou Z; Patel M; Ng N; Hsieh MH; Orth AP; Walker JR; Batalov S; Harris JL; Liu J
BMC Cancer; 2014 Dec; 14():944. PubMed ID: 25495526
[TBL] [Abstract][Full Text] [Related]
76. Integration of genomic data enables selective discovery of breast cancer drivers.
Sanchez-Garcia F; Villagrasa P; Matsui J; Kotliar D; Castro V; Akavia UD; Chen BJ; Saucedo-Cuevas L; Rodriguez Barrueco R; Llobet-Navas D; Silva JM; Pe'er D
Cell; 2014 Dec; 159(6):1461-75. PubMed ID: 25433701
[TBL] [Abstract][Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
